TAG
Abbott Laboratories
Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction
Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a trial over the safety of its formula...
Palo Alto shares helped by contract news, Abbott Labs braces for lawsuit ruling
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last...
Embattled Abbott Labs comes through with a strong quarter, buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose...
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. ReutersA version...